HCPCS Level IIdrugActive
J9043
Cabazitaxel injection
BETOS: O1D
Effective: 2012-01-01
Description
Injection, cabazitaxel, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Jevtana
Manufacturer
Sanofi-Aventis U.S. LLC
HCPCS Dosage
1 MG
Billing Units
60.0000
1
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.